FIELD: chemistry; pharmaceuticals; medicine.
SUBSTANCE: invention relates to a method for obtaining a new chemical compound, a derivative of N4-hydroxycytidine, which can be used to inhibit the replication of RNA and DNA-containing viruses (coronavirus, arbovirus). The invention relates to the field of organic chemistry and pharmaceuticals, and in particular to a method for obtaining a new derivative of N4-hydroxycytidine, which can be used to inhibit the replication of RNA and DNA-containing viruses. Disclosed is a method for preparing 5'-O-(3-phenylpropionyl)-N4-hydroxycytidine fromβ -D-N4-hydroxycytidine, including: (a) blocking vicinal 2' and 3' hydroxyl groups with acetonide protection to give intermediate 5'-O-(3-phenylpropionyl)-N4-hydroxycytidine; (b) blocking the hydroxyl group in 4' the position of N4-hydroxycytidine with a trityl protecting group to give the intermediate N4-trityloxy-2',3'-O-isopropylidenecytidine; (c) reaction of N4-trityloxy-2',3'-O-isopropylidenecytidine with phenylpropionic acid in the presence of 1,3-dicyclohexylcarbodiimide in methylene chloride to give the intermediate 3-phenylpropionic acid 2,2-dimethyl-6-(2- oxo-4-trityloxyamino-2H-pyrimidin-1-yl)-tetrahydro-furo[3,4-d][1,3]dioxol-4-yl methyl ester; (d) acid hydrolysis of the 3-phenylpropionic acid intermediate 2,2-dimethyl-6-(2-oxo-4-trityloxyamino-2H-pyrimidin-1-yl)-tetrahydro-furo[3,4-d][1,3]dioxol-4-yl methyl ester to form 5'-O-(3-phenylpropionyl)-N4-hydroxycytidine.
EFFECT: obtaining a new ester derivative of N4-hydroxycytidine with carboxylic acid in high yield.
4 cl, 6 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
5'-O-(3-PHENYLPROPIONYL)-N4-HYDROXYCYTIDINE AND ITS APPLICATION | 2022 |
|
RU2791523C1 |
5'-O-(4-PHENYLBUTANOYL)-N4-HYDROXYCYTIDINE AND USE THEREOF | 2023 |
|
RU2817201C1 |
5'-O-(4-CHLOROPHENOXYACETYL)-N4-HYDROXYCYTIDINE AND USE THEREOF | 2023 |
|
RU2817609C1 |
USE OF 5'-O-(3-PHENYLPROPIONYL)-N4-HYDROXYCYTIDINE TO INHIBIT INFLUENZA VIRUS REPLICATION IN VITRO AND IN VIVO | 2022 |
|
RU2791806C1 |
URACIL DERIVATIVES WITH ANTIVIRAL ACTIVITY AGAINST SARS-COV-2 | 2021 |
|
RU2769828C1 |
MODIFIED ANTISENSE OLIGONUCLEOTIDE AGAINST SARS-CoV-2 | 2020 |
|
RU2750584C1 |
mRNA-BASED VECTOR FOR INCREASED TARGET PROTEIN PRODUCTION IN MAMMALIAN CELLS (VARIANTS) | 2022 |
|
RU2792231C1 |
AGENT FOR INDUCTION OF SPECIFIC IMMUNITY AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-COV-2) IN LIQUID FORM (VERSIONS) | 2021 |
|
RU2743963C1 |
AGENT FOR INDUCTION OF SPECIFIC IMMUNITY AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-COV-2) IN LYOPHILIZED FORM (VERSIONS) | 2021 |
|
RU2743962C1 |
IMMUNOBIOLOGICAL AGENT AND METHOD FOR ITS USE FOR INDUCTION OF SPECIFIC IMMUNITY AGAINST VIRUSES SARS-COV-2 VARIANT B.1.617.2 (DELTA) AND SARS-COV-2 VARIANT B.1.1.529 (OMICRON) (VARIANTS) | 2022 |
|
RU2779634C1 |
Authors
Dates
2023-03-14—Published
2022-12-08—Filed